These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
3. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253 [TBL] [Abstract][Full Text] [Related]
4. Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. Goldzieher JW J Reprod Med; 1983 Jan; 28(1 Suppl):53-6. PubMed ID: 6403700 [TBL] [Abstract][Full Text] [Related]
6. Rationale for new oral contraceptive dosing. Williams JK Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507 [TBL] [Abstract][Full Text] [Related]
7. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
8. [Hypophyseal reaction state during oral contraceptiva (author's transl)]. Gitsch E; Schneider WH; Schmid R; Spona J Wien Klin Wochenschr; 1981 Oct; 93(19):599-601. PubMed ID: 6798764 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol. Akerlund M Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641 [TBL] [Abstract][Full Text] [Related]
11. [Oral contraception: evolution of concepts over the last thirty years]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408 [TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
13. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene]. Belaisch J; Hommais-loufrani B Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078 [TBL] [Abstract][Full Text] [Related]
14. New concepts in oral contraceptive pill use. Zacur HA; Stewart D Curr Opin Obstet Gynecol; 1992 Jun; 4(3):365-71. PubMed ID: 1623147 [TBL] [Abstract][Full Text] [Related]
15. Contraception with levonorgestrel, 0.15 mg, and ethinyl estradiol, 0.03 mg. Clinical studies in Latin America. Moggia AV J Reprod Med; 1983 Jan; 28(1 Suppl):77-80. PubMed ID: 6403704 [TBL] [Abstract][Full Text] [Related]
16. [Post-coital contraception]. Serfaty D Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):359-64. PubMed ID: 12280207 [TBL] [Abstract][Full Text] [Related]
18. Clinical experience with a low-dose contraceptive agent. European studies. Haspels AA J Reprod Med; 1983 Jan; 28(1 Suppl):71-6. PubMed ID: 6403703 [TBL] [Abstract][Full Text] [Related]
19. Three triphasic oral contraceptives now available in U.S. Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912 [TBL] [Abstract][Full Text] [Related]
20. [Hormonal contraceptives and arterial hypertension]. Janaszek-Sitkowska H Pol Tyg Lek; 1984 Oct 1-8; 39(40-41):1341-3. PubMed ID: 6393087 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]